Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from...

Por Smyth, L. M., Iyengar, N. M., Chen, M. F., Popper, S. M., Patil, S, Wasserheit-Lieblich, C., Argolo, D. F., Singh, J. C., Chandarlapaty, S, Sugarman, S. M., Comen, E. A., Drullinsky, P. R., Traina, T. A., Troso-Sandoval, T, Baselga, J, Norton, L, Hudis, C. A., Dang, C. T.
Publicado no Breast Cancer Res Treat (2016)